Coleen Glessner - 01 Mar 2026 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
01 Mar 2026
Net transactions value
-$2,551
Form type
4
Filing time
03 Mar 2026, 16:16:51 UTC
Previous filing
10 Feb 2026
Next filing
05 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Glessner Coleen EVP, Quality & Ethics, and CPL 300 PROFESSIONAL DRIVE, GAITHERSBURG /s/ Richard S. Lindahl, Attorney-in-fact 03 Mar 2026 0001919170

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $2,551 -313 -0.28% $8.15 112,307 01 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units.